Esbriet and Cachexia - a phase IV clinical study of FDA data
Summary:
Cachexia is reported as a side effect among people who take Esbriet (pirfenidone), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Ofev, and have Idiopathic pulmonary fibrosis.
The phase IV clinical study analyzes which people have Cachexia when taking Esbriet. It is created by eHealthMe based on reports of 39,843 people who have side effects when taking Esbriet from the FDA, and is updated regularly.
What is Esbriet?
Esbriet has active ingredients of pirfenidone. eHealthMe is studying from 39,858 Esbriet users. Check the latest studies of Esbriet.
What is Cachexia?
Cachexia (loss of weight) is found to be associated with 699 drugs and 1,198 conditions by eHealthMe. Check the latest studies of Cachexia.
39,843 people reported to have side effects when taking Esbriet.
Among them, 8 people (0.02%) have Cachexia.

Among these 8 people:
How long have people been on Esbriet when they have Cachexia? *
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 80 %
- 1 - 2 years: 20 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Cachexia when taking Esbriet? *
- female: 0.0 %
- male: 100 %
What is the age of people who have Cachexia when taking Esbriet? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
What are other drugs people take besides Esbriet? *
- Ofev: 4 people, 50.00%
- Zithromax: 2 people, 25.00%
- Prednisone: 2 people, 25.00%
- Omeprazole: 2 people, 25.00%
- Ezetimibe: 2 people, 25.00%
- St. John's Wort: 1 person, 12.50%
- Pepcid: 1 person, 12.50%
- Nitrostat: 1 person, 12.50%
- Metoprolol Succinate: 1 person, 12.50%
- Lasix: 1 person, 12.50%
What are other side effects people have besides Cachexia? *
- Weight Decreased: 4 people, 50.00%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 37.50%
- Pneumonia: 2 people, 25.00%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 25.00%
- Cough: 2 people, 25.00%
- Depression: 1 person, 12.50%
- Abdominal Pain: 1 person, 12.50%
- Abdominal Pain Upper: 1 person, 12.50%
- Abnormal Faeces (abnormal stool): 1 person, 12.50%
- Abnormal Loss Of Weight: 1 person, 12.50%
What are the existing conditions these people have? *
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 8 people, 100.00%
- Depression: 1 person, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take Esbriet and have Cachexia?
- Check whether Cachexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Esbriet:
- Esbriet (39,858 reports)
Cachexia treatments and more:
- Cachexia (7,763 reports)
How severe was Cachexia and when was it recovered:
Expand to all the drugs that have ingredients of pirfenidone:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Esbriet:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Cachexia:
- Cachexia (699 drugs)
Browse all the conditions that are associated with Cachexia:
- Cachexia (1,198 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on pirfenidone (the active ingredients of Esbriet) and Esbriet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Primidone and Trilipix - 27 seconds ago
- Drug interactions of Dilaudid and Demerol - 33 seconds ago
- Drug interactions of Urocit-K and Heparin - 49 seconds ago
- Lung Neoplasm Malignant and Raynaud'S Phenomenon - 50 seconds ago
- Could Glucosamine cause Stroke? - a minute ago
- Levemir vs. Humalog Pen, side effect and effectiveness comparison - a minute ago
- Drug interactions of Excedrin and Nabumetone - a minute ago
- Drug interactions of Klor-Con and Coq10 - 2 minutes ago
- Schizoaffective Disorder and Birth Control - 2 minutes ago
- Drug interactions of Piroxicam and Roxicet - 3 minutes ago